BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7209388)

  • 1. The parietal cells in duodenal ulcer patients. A quantitative ultrastructural study before and during treatment with cimetidine.
    Nielsen H; Madsen PE; Christiansen LA
    Scand J Gastroenterol; 1980; 15(7):793-7. PubMed ID: 7209388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructure of duodenal epithelial cells in patients with active duodenal ulcers and after treatment with cimetidine.
    Pillay CV; Moshal MG; Bryer JV; Booyens J
    S Afr Med J; 1977 Dec; 52(27):1082-5. PubMed ID: 609983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the duodenal cell ever return to normal? A comparison between treatment with cimetidine and denol.
    Moshal MG; Gregory MA; Pillay C; Spitaels JM
    Scand J Gastroenterol Suppl; 1979; 54():48-51. PubMed ID: 295504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine treatment on parietal and chief cell sensitivity to histamine and on catabolism of histamine in duodenal ulcer patients.
    Aadland E; Berstad A; Granerus G
    Scand J Gastroenterol; 1980; 15(6):749-54. PubMed ID: 6782649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxepin and cimetidine in the treatment of duodenal ulcer: an open clinical and endoscopic study.
    Ruud TE; Hoff GS; Tonder M; Holter O
    J Clin Psychiatry; 1982 Aug; 43(8 Pt 2):56-60. PubMed ID: 7096279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parietal cell mass after short and long term cimetidine treatment of duodenal ulcer.
    Cheli R; Giacosa A; Molinari F; Ferrari C
    Scand J Gastroenterol Suppl; 1979; 54():45-7. PubMed ID: 295503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine in the treatment of duodenal ulcer: review and commentary.
    Winship DH
    Gastroenterology; 1978 Feb; 74(2 Pt 2):402-6. PubMed ID: 340330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parietal and chief cell sensitivity to pentagastrin stimulation before and after cimetidine treatment for duodenal ulcer.
    Aadland E; Berstad A
    Scand J Gastroenterol; 1979; 14(1):111-14. PubMed ID: 370968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proximal gastric vagotomy; effect on parietal and non-parietal components of gastric secretion. Comparison with effects obtained with cimetidine].
    Castro Rial M; Toni Sterling P; García Morato V; Piñón Cimadevilla MA; Campelo Nuñez F
    Rev Esp Enferm Apar Dig; 1981 Aug; 60(2):137-48. PubMed ID: 7031795
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of a histamine H2 receptor antagonist (cimetidine) on gastrin and insulin secretion in peptic ulcer patients].
    Elicio N; Chiodini G; Bertolini S; Pronzato P; Valice S
    Arch Maragliano Patol Clin; 1978; 34(2):121-8. PubMed ID: 400549
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of oxmetidine and cimetidine in the treatment of duodenal ulcer.
    Barbezat GO; Brown D; Schlup M; Maclaurin BP
    N Z Med J; 1983 Apr; 96(729):250-2. PubMed ID: 6340009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of smoking on duodenal ulcer healing with cimetidine and oxmetidine.
    Gugler R; Rohner HG; Kratochvil P; Brandstätter G; Schmitz H
    Gut; 1982 Oct; 23(10):866-71. PubMed ID: 6126423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cimetidine treatment of recurrent ulcer after proximal gastric vagotomy.
    Berstad A; Aadland E; Bjerke K
    Scand J Gastroenterol; 1981; 16(7):891-6. PubMed ID: 7034163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cimetidine--is it the final common pathway for duodenal ulcers.
    Joffe SN
    Scott Med J; 1977 Oct; 22(4):301-3. PubMed ID: 929176
    [No Abstract]   [Full Text] [Related]  

  • 15. Histamine-2-receptor blocker cimetidine in African patients with duodenal ulceration--a preliminary communication.
    Wasunna JB
    East Afr Med J; 1979 Jan; 56(1):42-4. PubMed ID: 35333
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cimetidine in the treatment of peptic ulcer].
    Pera A; Lombardo L; Crivelli O; Verme G
    Minerva Med; 1977 Oct; 68(47):3277-82. PubMed ID: 335279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotidine, a new H2-receptor antagonist, is a potent inhibitor of nocturnal acid secretion in duodenal ulcer patients.
    Valenzuela JE; Strecker RB; Douglas AP
    Dig Dis Sci; 1981 May; 26(5):433-7. PubMed ID: 6113920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of duodenal ulcer with various dosages of cimetidine. Results of a clinical-endoscopic study].
    Zaccardelli E; Proietti F; Ricotta G; Carratù R; Paoluzi P
    Clin Ter; 1980 Nov; 95(3):279-87. PubMed ID: 7214843
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and endoscopic observations on the effects of treatment of duodenal ulcer with Chinese-made cimetidine in 40 cases (author's transl)].
    Jia JF
    Zhonghua Nei Ke Za Zhi; 1979; 18(6):412-4. PubMed ID: 555949
    [No Abstract]   [Full Text] [Related]  

  • 20. The antral gastrin-producing cells in duodenal ulcer patients. An ultrastructural study before and during treatment with cimetidine.
    Nielsen HO; Hage E
    Virchows Arch A Pathol Anat Histopathol; 1985; 406(3):271-7. PubMed ID: 3923703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.